Recursion Stock Soars After Nvidia Invests $50 Million for AI Drug Discovery

Recursion Pharmaceuticals stock has gained more than 150%.

Related Keywords

Chris Gibson ,Jensen Huang ,Recursion Pharmaceuticals ,Nvidia ,Tae Kim ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Computers Consumer Electronics ,Artificial Intelligence Technologies ,Semiconductors ,Healthcare Life Sciences ,Computing ,Computer Hardware ,Industrial Electronics ,Industrial Goods ,Integrated Circuits ,Technology ,Graphics Processing Units ,Corporate Funding ,Corporate Industrial News ,Private Placements ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Biotech And Pharma ,Nvda ,Rxrx ,Recursion ,Corporate ,Industrial News ,Computers ,Consumer Electronics ,Healthcare ,Life Sciences ,